Final multivariate model results indicated that the methylation levels of these two CpG sites did not remain statistically associated with persistent DS in the total study population (FKBP5-12 CpG 1: OR = 0.77; 95% CI, 0.58–1.01; P = 0.055; FKBP5-47 CpG 36: OR = 0.95; 95% CI, 0.89-1.00; P = 0.063). Here, FKBP5 is linked to Dravet syndrome.